EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS

EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS

Show other versions (1)

The article presents a case report of a patient with juvenile rheumatoid arthritis refractory to the treatment with metothrexate. Combined therapy with metothrexate and leflunomide induced development of unfavorable effects resulted in cancellation of leflunomide. Successful administration of biolog...

Full description

Bibliographic Details
Main Authors:	Ye. I. Alekseyeva, S. I. Valiyeva, T. V. Sleptsova
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2011-01-01
Series:	Вопросы современной педиатрии
Subjects:	children juvenile rheumatoid arthritis abatacept treatment
Online Access:	https://vsp.spr-journal.ru/jour/article/view/557

Similar Items

EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: INTERNATIONAL DATA AND EXPERIENCE OF USAGE IN THE REPUBLIC OF MORDOVIA
by: L. A. Balykova, et al.
Published: (2014-03-01)

EXPERIENCE OF ABATACEPT TREATMENT IN A PATIENT WITH ANTIBODY-POSITIVE IDIOPATHIC JUVENILE ARTHRITIS
by: T. M. Bzarova, et al.
Published: (2012-03-01)

EXPERIENCE OF TREATMENT OF THE TWINS SICK WITH JUVENILE IDIOPATHIC ARTHRITIS BY ABATACEPT
by: V. A. Kel'tsev
Published: (2014-05-01)

EXPERIENCE WITH ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: Margarita Fedorovna Dubko, et al.
Published: (2012-10-01)

METHOTREXATE — «GOLD STANDARD» OF JUVENILE RHEUMATOID ARTHRITIS TREATMENT
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

METHOTREXATE — «GOLD STANDARD» OF JUVENILE RHEUMATOID ARTHRITIS TREATMENT
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012-11-01)

Experience with abatacept used in the treatment of patients with rheumatoid arthritis
by: V I Mazurov, et al.
Published: (2011-12-01)

Efficacy of Abatacept Therapy in a Patient with Juvenile Idiopathic Arthritis and Bilateral Uveitis
by: Lelia A. Galstian, et al.
Published: (2016-08-01)

Use of abatacept in rheumatoid arthritis
by: Johannes von Kempis, et al.
Published: (2012-05-01)

RESULTS OF THE IV PHASE OF THE OPEN CLINICAL TRIAL ON EFFICACY AND SAFETY OF ABATACEPT USAGE IN CHILDREN AND ADOLESCENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS IN RUSSIA
by: E. I. Alexeeva, et al.
Published: (2013-07-01)

Efficacy, safety and tolerability of using abatacept for the treatment of rheumatoid arthritis
by: Rafael Venson, et al.
Published: (2012-12-01)

Abatacept and cardiovascular risk in rheumatoid arthritis: update
by: T. V. Popkova
Published: (2018-01-01)

EFFICACY OF ABATACEPT IN A PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS REFRACTORY TO TNF-α
by: Yu. M. Spivakovskii, et al.
Published: (2015-04-01)

Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
by: Waka Yokoyama-Kokuryo, et al.
Published: (2020-03-01)

Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis
by: C. Derambure, et al.
Published: (2017-05-01)

Cost-utility analysis of abatacept in rheumatoid arthritis in Italy
by: Simona de Portu, et al.
Published: (2008-03-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH DIFFERENT DURATION OF RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-01-01)

Multicenter, observational clinical study of abatacept in Japanese patients with rheumatoid arthritis
by: Noriyoshi Ogawa, et al.
Published: (2019-01-01)

Safety and efficacy of abatacept among patients with refractory rheumatoid arthritis: Experience from a North Indian Tertiary Care Hospital
by: M N Arjun, et al.
Published: (2018-01-01)

Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease
by: Natalia Mena-Vázquez, et al.
Published: (2022-06-01)

Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
by: Shuzo Sato, et al.
Published: (2021-08-01)

Impact of concomitant methotrexate on disease activity in patients with rheumatoid arthritis tapering abatacept: results from KOBIO registry
by: Jun Won Park, et al.
Published: (2024-07-01)

Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive
by: Leslie R. Harrold, et al.
Published: (2024-01-01)

Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors—data from a large national quality register
by: Giovanni Cagnotto, et al.
Published: (2020-01-01)

Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis
by: Takeshi Iwasaki, et al.
Published: (2024-01-01)

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018-03-01)

The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis
by: Alberto Floris, et al.
Published: (2025-01-01)

Evaluation of B cell related markers and autoantibodies in rheumatoid arthritis patients treated with abatacept
by: Ting Wang, et al.
Published: (2025-01-01)

RAISE – Rheumatoid Arthritis Independent Swiss Treatment Expectations and Outcome: results for the abatacept subpopulation
by: Jean Dudler, et al.
Published: (2013-12-01)

Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis
by: Wataru Hirose, et al.
Published: (2021-08-01)

Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
by: Ernest Choy, et al.
Published: (2021-02-01)

Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study
by: Zento Yamada, et al.
Published: (2024-04-01)

S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
by: Hermine I Brunner, et al.
Published: (2024-06-01)

Predicting abatacept retention using machine learning
by: Rieke Alten, et al.
Published: (2025-02-01)

Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy
by: Roberto Caporali, et al.
Published: (2021-07-01)

Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept
by: Louis Bessette, et al.
Published: (2023-09-01)

Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT
by: Sarah Brown, et al.
Published: (2018-06-01)

Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries
by: Alyssa Dominique, et al.
Published: (2023-06-01)